Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases. Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Single cell RNA-seq analysis of PBMCs testing for a synergistic effect of TLR7/8 inhibition and the glucocorticoid dexamethasone Overall design: Isolated PBMCs of four healthy human blood donor leukopaks, treated with a TLR7 and/or TLR8 inhibitor and/or dexamethasone
创建时间：
2023-06-27
